Sun Pharmaceutical Industries Limited announced that Mr. Ashok I Bhuta will cease to be the Compliance Officer of the Company with effect from close of business hours on May 31, 2022 as a result of completion of his tenure in the employment of the Company.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,494 INR | +1.86% |
|
-1.42% | +18.66% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+18.66% | 42.12B | |
+23.31% | 21.72B | |
+20.71% | 14.89B | |
+56.75% | 13.06B | |
-0.05% | 6.79B | |
-12.68% | 6.3B | |
+17.73% | 6.05B | |
-8.87% | 5.73B | |
+6.11% | 4.58B | |
+23.18% | 4.4B |
- Stock Market
- Equities
- SUNPHARMA Stock
- News Sun Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Limited Announces Cessation of Mr. Ashok I Bhuta as Compliance Officer